Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | GSK to Present at COPD Summit 2013New Speaker Annoucement | COPD | 16th - 17th October 2013, London UK
By: SMI Group The presentation follows on from GlaxoSmithKline and Theravance’ “After more than a decade of joint respiratory research and development, the approval is a very important milestone for Theravance and GSK.” Rick E Winningham, Chief Executive Officer of Theravance. Source GSK Press Release Issued: Friday 10 May 2013 The new presentation will provide attendees with a unique insight into P13Kdelta. GSK Presentation highlights will include: • Overview and importance of PI3K delta inhibition • Pre-clinical case study data • Effect on inflammatory burden and exacerbations • Future outlook and use if PI3K inhibitors in treating COPD The conference taking place on 16th and 17th October 2013 will also feature presentations from AstraZeneca, Aquinox Pharmaceuticals, Pfizer and Teva. Conference Highlights will include: • Novel diagnostic techniques and methods that can improve identifying early stages of the disease. • Focus on sessions involving the latest on alternative causations, exacerbations, and small airways disease. • Discussions on advances and challenges in the development of treatment methods and strategies to improve patient treatment adherence. For further details on the event visit www.smi-online.co.uk/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|